Search results for "Therapeutics"
Electronic medication reconciliation not associated with better postdischarge outcomes
A recent cluster randomized trial looked at whether an electronic system that retrieved insurer information on outpatient medications affected adverse drug events, readmissions, or mortality in the 30 days after discharge.
https://acphospitalist.acponline.org/weekly/archives/2019/09/25/3.htm
25 Sep 2019
Stopping the cycle of C. diff
Microbiota therapies offer exciting potential to reduce the burden of recurrent Clostridioides difficile infection, experts say.
https://acphospitalist.acponline.org/archives/2023/02/08/free/stopping-the-cycle-of-c-diff.htm
8 Feb 2023
Moderate hypothermia improved neurologic outcomes after cardiac arrest with nonshockable rhythm
Mortality was similar whether patients were randomized to a target temperature of 33 °C or 37 °C, but those in the former group were more likely to have a favorable Cerebral Performance Category score at 90 days.
https://acphospitalist.acponline.org/weekly/archives/2019/10/09/4.htm
9 Oct 2019
Cefepime-induced neurotoxicity
An elderly patient presented with confusion three days after a hospitalization for osteomyelitis.
https://acphospitalist.acponline.org/archives/2023/07/12/free/cefepime-induced-neurotoxicity.htm
12 Jul 2023
Latest COVID-19 research looks at plasma, prophylaxis, palliative care, periop risks
The benefit of convalescent plasma is uncertain, and hydroxychloroquine did not appear to work for prophylaxis, according to new studies. Experts offered advice on using palliative care, avoiding surgery, changing residency applications, and understanding antibody testing.
https://acphospitalist.acponline.org/weekly/archives/2020/06/10/1.htm
10 Jun 2020
Hospitalists can help eliminate HCV
Hospitals are the latest frontier in global efforts to diagnose and treat hepatitis C virus (HCV).
https://acphospitalist.acponline.org/archives/2023/01/11/free/hospitalists-can-help-eliminate-hcv.htm
11 Jan 2023
Latest COVID-19 research focuses on another drug, racial disparities, early infections
A Brazilian trial found benefit from tofacitinib in hospitalized patients, while a study of Medicare patients showed racial disparities might stem from differences between hospitals.
https://acphospitalist.acponline.org/weekly/archives/2021/06/23/1.htm
23 Jun 2021
Combating clots in COVID-19
Critical care experts advised on appropriate prophylaxis for ward and ICU patients as part of the CHEST 2021 conference.
https://acphospitalist.acponline.org/archives/2021/11/combating-clots-in-covid-19.htm
15 Nov 2021
Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://acphospitalist.acponline.org/weekly/archives/2020/10/21/1.htm
21 Oct 2020
Primum non nocere
Two hospitalists muse on the current pandemic.
https://acphospitalist.acponline.org/archives/2020/09/primum-non-nocere.htm
15 Sep 2020